Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SGTX

Sigilon Therapeutics (SGTX) Stock Price, News & Analysis

Sigilon Therapeutics logo

About Sigilon Therapeutics Stock (NASDAQ:SGTX)

Advanced Chart

Key Stats

Today's Range
$22.47
$22.47
50-Day Range
$20.92
$23.06
52-Week Range
$3.77
$28.00
Volume
N/A
Average Volume
62,902 shs
Market Capitalization
$56.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SGTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sigilon Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SGTX Stock News Headlines

Lilly & Co Eli's Net Worth
MCRB Seres Therapeutics, Inc.
This Coin Could Explode, and it’s Hiding in Plain Sight!
The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain sight...tc pixel
Beam Therapeutics Inc.
Eli Lilly Concludes Acquisition Of Sigilon Therapeutics
Lilly Completes Acquisition of Sigilon Therapeutics
SGTX - Sigilon Therapeutics, Inc.
See More Headlines

SGTX Stock Analysis - Frequently Asked Questions

Sigilon Therapeutics, Inc. (NASDAQ:SGTX) posted its earnings results on Wednesday, November, 10th. The company reported ($8.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($8.58) by $0.39. The business earned $1.95 million during the quarter, compared to analyst estimates of $3.20 million. Sigilon Therapeutics had a negative trailing twelve-month return on equity of 83.07% and a negative net margin of 171.29%.

Shares of Sigilon Therapeutics reverse split on Tuesday, May 23rd 2023.The 1-13 reverse split was announced on Tuesday, May 23rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Sigilon Therapeutics (SGTX) raised $101 million in an IPO on Friday, December 4th 2020. The company issued 5,600,000 shares at $17.00-$19.00 per share. Morgan Stanley, Jefferies, Barclays and Canaccord Genuity served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sigilon Therapeutics investors own include Tesla (TSLA), NIO (NIO), Athenex (ATNX), Plug Power (PLUG), CrowdStrike (CRWD) and Li Auto (LI).

Company Calendar

Last Earnings
11/10/2021
Today
9/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SGTX
CIK
1821323
Fax
N/A
Employees
62
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($12.2328)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$43.56 million
Net Margins
-171.29%
Pretax Margin
-171.29%
Return on Equity
-83.07%
Return on Assets
-38.17%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.78
Quick Ratio
1.78

Sales & Book Value

Annual Sales
$12.94 million
Price / Sales
4.36
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$15.68 per share
Price / Book
1.43

Miscellaneous

Outstanding Shares
2,510,000
Free Float
2,351,000
Market Cap
$56.40 million
Optionable
Not Optionable
Beta
4.12

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:SGTX) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners